Literature DB >> 19293458

Large animal models of neurological disorders for gene therapy.

Christine Gagliardi1, Bruce A Bunnell.   

Abstract

he development of therapeutic interventions for genetic disorders and diseases that affect the central nervous system (CNS) has proven challenging. There has been significant progress in the development of gene therapy strategies in murine models of human disease, but gene therapy outcomes in these models do not always translate to the human setting. Therefore, large animal models are crucial to the development of diagnostics, treatments, and eventual cures for debilitating neurological disorders. This review focuses on the description of large animal models of neurological diseases such as lysosomal storage diseases, Parkinsons disease, Huntingtons disease, and neuroAIDS. The review also describes the contributions of these models to progress in gene therapy research.

Entities:  

Mesh:

Year:  2009        PMID: 19293458      PMCID: PMC2712138          DOI: 10.1093/ilar.50.2.128

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  219 in total

Review 1.  Viral vectors for gene therapy.

Authors:  P D Robbins; S C Ghivizzani
Journal:  Pharmacol Ther       Date:  1998-10       Impact factor: 12.310

2.  Bone marrow transplantation for the treatment of alpha-mannosidosis.

Authors:  D A Wall; D K Grange; P Goulding; M Daines; A Luisiri; S Kotagal
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

3.  Changes in cell-cycle kinetics during the development and evolution of primate neocortex.

Authors:  D R Kornack; P Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

4.  Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

Authors:  R J Mandel; K G Rendahl; S K Spratt; R O Snyder; L K Cohen; S E Leff
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

5.  Krabbe disease: an ultrastructural study of globoid cells and reactive astrocytes at the brain and optic nerves.

Authors:  D Jesionek-Kupnicka; A Majchrowska; J Krawczyk; J Wendorff; M Barcikowska; S Lukaszek; P P Liberski
Journal:  Folia Neuropathol       Date:  1997       Impact factor: 2.038

Review 6.  Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status.

Authors:  K Suzuki
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

7.  Development of a self-inactivating lentivirus vector.

Authors:  H Miyoshi; U Blömer; M Takahashi; F H Gage; I M Verma
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.

Authors:  J Ray; A Bouvet; C DeSanto; J C Fyfe; D Xu; J H Wolfe; G D Aguirre; D F Patterson; M E Haskins; P S Henthorn
Journal:  Genomics       Date:  1998-03-01       Impact factor: 5.736

9.  In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.

Authors:  M J During; R J Samulski; J D Elsworth; M G Kaplitt; P Leone; X Xiao; J Li; A Freese; J R Taylor; R H Roth; J R Sladek; K L O'Malley; D E Redmond
Journal:  Gene Ther       Date:  1998-06       Impact factor: 5.250

10.  Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Authors:  R Zufferey; T Dull; R J Mandel; A Bukovsky; D Quiroz; L Naldini; D Trono
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  6 in total

Review 1.  Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems.

Authors:  Marilyn N Martinez
Journal:  AAPS J       Date:  2011-10-05       Impact factor: 4.009

2.  Gene therapy in large animal models of human genetic diseases. Introduction.

Authors:  John H Wolfe
Journal:  ILAR J       Date:  2009

Review 3.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

4.  Gene transfer to the CNS using recombinant adeno-associated virus.

Authors:  Lorelei Stoica; Seemin S Ahmed; Guangping Gao; Miguel Sena-Esteves
Journal:  Curr Protoc Microbiol       Date:  2013

5.  Towards human central nervous system in vitro models for preclinical research: strategies for 3D neural cell culture.

Authors:  Daniel Simão; Inês Costa; Margarida Serra; Johannes Schwarz; Catarina Brito; Paula M Alves
Journal:  BMC Proc       Date:  2011-11-22

Review 6.  Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side.

Authors:  Laura Garcia-Perez; Anita Ordas; Kirsten Canté-Barrett; Pauline Meij; Karin Pike-Overzet; Arjan Lankester; Frank J T Staal
Journal:  Pharmaceutics       Date:  2020-06-13       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.